-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_disposition-comments.pdf
January 07, 2016 - Introduction: The question of whether the diagnosis of "CIN" is really AKI secondary
to contrast or … contrast is also likely to be receiving statin therapy (given their widespread
using in primary and secondary … However, while the CIN outcome was not included, the investigators chose to use the
ACT study for secondary … CIN, was not included in the primary
analyses of NAC and CIN (though it seems to be included in a secondary
-
www.ahrq.gov/hai/cauti-tools/cauti-icu/facil-guide/mod1.html
February 01, 2023 - for Disease Control and Prevention’s National Healthcare Safety Network, and are the leading cause of secondary
-
www.ahrq.gov/sites/default/files/wysiwyg/research/publications/pubcomguide/Shooting-Script-How-to.pdf
July 01, 2024 - OC will help you identify primary and secondary keywords that fit the video’s content and are
likely
-
www.ahrq.gov/sites/default/files/2024-01/grahamlear-report.pdf
January 01, 2024 - Pharmaceutical Association summarized the current
knowledge about medication management in primary and secondary
-
psnet.ahrq.gov/web-mm/failure-latch
November 27, 2012 - enterohepatic circulation, sometimes called starvation jaundice, aggravated by inadequate milk intake secondary
-
psnet.ahrq.gov/web-mm/case-mistaken-intubation
July 01, 2016 - been discharged from the hospital after a prolonged and complicated hospitalization for severe sepsis secondary
-
psnet.ahrq.gov/node/866205/psn-pdf
July 10, 2024 - and immediate transfusion should have been initiated with laboratory testing and imaging as distant
secondary
-
psnet.ahrq.gov/node/33875/psn-pdf
March 01, 2019 - The
person in the secondary hospital is trying to figure out who to call because it's not clear.
-
psnet.ahrq.gov/web-mm/hazards-distraction-ticking-all-ehr-boxes
April 09, 2014 - The surgery was uncomplicated, but postoperatively she developed sepsis secondary to a hospital-acquired
-
psnet.ahrq.gov/node/33839/psn-pdf
August 01, 2017 - We also measured a number of secondary outcomes: wound infections, renal failure, sepsis,
and readmissions
-
psnet.ahrq.gov/node/33710/psn-pdf
May 01, 2011 - But I think that is a secondary gain for our second victims.
-
hcup-us.ahrq.gov/reports/methods/2000NISComparisonReportFinal.pdf
February 28, 2003 - If a symptom appears as a first-listed
code and a diagnosis appears as a secondary code, the diagnosis … If a symptom appears as a first-
listed code and a diagnosis is
listed as a secondary code, the
diagnosis … comparing NIS records to MedPAR, only the NIS discharges for which
Medicare was the expected primary or secondary … For example, when
a symptom appeared as the first-listed code, it was reassigned as a secondary diagnosis … For researchers interested in discharges for which
Medicare is a secondary payer, the NIS is the only
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core.PDF
January 01, 2010 - 1.00 0.29 0.45
PAY1 : Primary expected payer
(uniform) 7,781,931 18,510 1.00 6.00 2.20 1.21
PAY2 : Secondary … OTHER O.R.PROC 1,332 0.02%
409: RADIOTHERAPY 1,032 0.01%
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 29,506 0.38%
464: SIGNS & SYMPTOMS W/O CC 8,320 0.11%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 225 0.00%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 2,871 0.04%
467 … 0.11%
40: Multiple myeloma 3,826 0.05%
41: Cancer; other and unspecified primary 1,816 0.02%
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Core_Weighted.PDF
January 01, 2010 - 0.00 1.00 0.29 0.00
PAY1 Primary expected
payer (uniform)
7,781,931 18,510 1.00 6.00 2.21 0.01
PAY2 Secondary … OTHER O.R.PROC 6,725 0.02%
409: RADIOTHERAPY 5,257 0.01%
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 147,543 0.38%
464: SIGNS & SYMPTOMS W/O CC 41,670 0.11%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1,113 0.00%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 14,189 0.04% … 0.12%
40: Multiple myeloma 19,277 0.05%
41: Cancer; other and unspecified primary 9,224 0.02%
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Core_Weighted.PDF
January 01, 2011 - Statistics
Variable Label N N Miss Minimum Maximum Mean
Std
Error
of Mean 95% CL for Mean
PAY2 Secondary … OTHER O.R.PROC 5,704 0.01%
409: RADIOTHERAPY 2,411 0.01%
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 142,269 0.37%
464: SIGNS & SYMPTOMS W/O CC 39,515 0.10%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1,187 0.00%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 12,858 0.03% … 0.11%
40: Multiple myeloma 18,248 0.05%
41: Cancer; other and unspecified primary 7,990 0.02%
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2009_MaskedStats_Core_Weighted.PDF
January 01, 2009 - 0.3008
PAY1 Primary expected payer (uniform) 7,794,273 16,489 1.00 6.00 2.21 0.01 2.1869 2.2353
PAY2 Secondary … Distribution for DRG24
DRG24 Frequency
Percent
of
Total
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 132,135 0.34%
464: SIGNS & SYMPTOMS W/O CC 41,204 0.10%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1,390 0.00%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 16,237 0.04% … 0.11%
40: Multiple myeloma 18,210 0.05%
41: Cancer; other and unspecified primary 7,416 0.02%
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core.PDF
January 01, 2007 - 31.00 1.61 2.02
PAY1 : Primary expected payer (uniform) 8025878 17537 1.00 6.00 2.25 1.21
PAY2 : Secondary … W CC 21944 0.27
464: SIGNS & SYMPTOMS W/O CC 7159 0.09
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 388 0.00
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 4244 0.05
467: … 8769 0.11
40: Multiple myeloma 3631 0.05
41: Cancer; other and unspecified primary 1696 0.02
42: Secondary … Distribution for DXCCS1
DXCCS1 Frequency
Percent
of
Total
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
January 01, 2009 - 0.25 0.25
PAY1 Primary expected payer (uniform) 3,401,922 5,224 1.00 6.00 2.65 0.01 2.64 2.67
PAY2 Secondary … CC 2,865 0.04%
464: SIGNS & SYMPTOMS W/O CC 3,992 0.05%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS <= 50 *.**%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 1,234 0.02% … 0.10%
40: Multiple myeloma <= 50 *.**%
41: Cancer; other and unspecified primary 1,985 0.03%
42: Secondary … disease) 3,683 0.05%
98: Essential hypertension 1,018 0.01%
99: Hypertension with complications and secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core.PDF
January 01, 2008 - 1.00 0.30 0.46
PAY1 : Primary expected payer (uniform) 8,144,696 13,685 1.00 6.00 2.23 1.20
PAY2 : Secondary … W OTHER O.R.PROC 1,271 0.02%
409: RADIOTHERAPY 816 0.01%
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 25,774 0.32%
464: SIGNS & SYMPTOMS W/O CC 8,701 0.11%
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 430 0.01%
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 4,227 0.05%
467 … 0.11%
40: Multiple myeloma 3,908 0.05%
41: Cancer; other and unspecified primary 1,729 0.02%
42: Secondary
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core.PDF
January 01, 2006 - 30.00 1.55 1.98
PAY1 : Primary expected payer (uniform) 8061232 13593 1.00 6.00 2.22 1.21
PAY2 : Secondary … NEOPL W OTHER O.R.PROC 1171 0.01
409: RADIOTHERAPY 987 0.01
410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … W CC 14479 0.18
464: SIGNS & SYMPTOMS W/O CC 4703 0.06
465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 501 0.01
466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 4812 0.06
467: … diseases) 18336 0.23
98: Essential hypertension 16768 0.21
99: Hypertension with complications and secondary